SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is trending as investors gear up for a pivotal earnings release, with the community actively speculating on whether the new management team can deliver on growth and profitability targets. Discussions center on the stock's potential for a significant move, with many focusing on recent operational progress and the strategic importance of this upcoming report as a catalyst for future performance.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is experiencing intense volatility as investors debate the impact of increased competition from private-label alternatives and concerns over inventory management versus the company's strong brand loyalty and shelf-space expansion. Community discussion is heavily focused on the stock's proximity to 52-week lows, with many traders looking for an earnings-driven catalyst to trigger a short squeeze or a trend reversal.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap Inc. is trending ahead of its quarterly earnings release as investors weigh the company's path to profitability against concerns regarding North American user growth and geopolitical headwinds. The community remains deeply divided, with bulls highlighting the stock's potential for a turnaround driven by cost-cutting and engagement, while bears express skepticism over leadership and ongoing competition in the social media sector.

Digi Power X, Inc. is a block chain technology company, which engages in crypto currency mining. It focuses on validation through mining, hosting solutions, and blockchain software solutions. It operates through the following segments: Cryptocurrency Mining, Sales of Energy and Electricity, and Colocation Services. The company was founded on February 18, 2017, and is headquartered in Miami, FL.

Digi Power X Inc. - Ordinary Shares (Sub voting)

Digi Power X is trending as investors react to a multi-billion dollar data center contract with AI chip maker Cerebras, fueling bullish sentiment despite concerns regarding dilution from their ATM offering. The community is actively discussing a potential squeeze driven by high short interest and anticipation surrounding the upcoming Cerebras IPO.

Corning, Inc. engages in the provision of glass for notebook computers, flat panel desktop monitors, display televisions, and other information display applications, carrier network and enterprise network products for the telecommunications industry, ceramic substrates for gasoline and diesel engines in automotive and heavy-duty vehicle markets, laboratory products for the scientific community and polymer products for biotechnology applications, optical materials for the semiconductor industry and the scientific community, and polycrystalline silicon products and other technologies. It operates through the following segments: Optical Communications, Display, Specialty Materials, Automotive, and Life Sciences. The Optical Communications segment is classified into two main product groupings: carrier and enterprise network. The carrier network group consists of products and solutions for optical-based communications infrastructure for services such as video, data, and voice communications. The enterprise network group consists primarily of optical-based communication networks sold to businesses, governments, and individuals for their own use. The Display Technologies segment manufactures glass substrates for flat panel displays, including organic light-emitting diodes and liquid crystal displays that are used primarily in televisions, notebook computers, desktop monitors, tablets, and handheld devices. The Specialty Materials segment is involved in the manufacture of products that provide material formulations for glass, glass ceramics and crystals, and precision metrology instruments and software. The Automotive segment manufactures ceramic substrates and filter products for emissions control in mobile applications around the world as well as technical glass and optic products and solutions for the interior and exterior of vehicles. The Life Sciences segment develops, manufactures, and supplies laboratory products. The company was founded by Amory Houghton Sr. in 1851 and is headquartered in Corning, NY.

Corning, Inc.

Corning is trending following a massive strategic partnership with NVIDIA, which includes a landmark manufacturing expansion to supply critical optical infrastructure for the booming AI data center market. Investors are closely monitoring the stock as it scales fiber production capacity to meet hyperscale demand, with the community actively debating whether this represents a long-term re-pricing of the company as an essential AI backbone or an overextended growth narrative.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

AppLovin is at the center of intense market debate as investors weigh strong earnings and exceptional profit margins against concerns over a potential mixed shelf offering. The stock has been characterized by extreme price volatility, with the community actively split between those focused on the long-term potential of the AI-driven AXON engine and those wary of institutional selling and ongoing regulatory scrutiny.

iShares Trust - iShares Semiconductor ETF

iShares Semiconductor ETF

The iShares Semiconductor ETF (SOXX) is seeing intense volatility as investors debate whether current record valuations reflect a sustainable AI-driven growth cycle or a speculative bubble reminiscent of the dot-com era. Community sentiment remains sharply divided, with bulls pointing to robust infrastructure demand while bears are actively scaling into inverse positions, citing extreme overbought indicators and rising risks from geopolitical instability.

Ernexa Therapeutics, Inc. engages in the provision of cell engineering therapies. It is involved in the development of mRNA cell engineering technologies to repair cellular dysfunction and treat a range of therapeutic indications. The company was founded in 1984 and is headquartered in Cambridge, MA.

Ernexa Therapeutics Inc.

Ernexa Therapeutics is trending as the community debates the validity of recent preclinical data for its ovarian cancer cell therapy, weighing promising lab results against historical concerns regarding reverse splits and dilution. Investors are actively discussing the potential for a short squeeze, given the company's low float and high borrow costs, while split camps argue whether the current valuation represents a deep-value opportunity or a recurring dilution trap.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing and Plasma Collection Center. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

Adma Biologics is currently drawing intense community focus as traders debate whether the recent sharp pullbackfueled by a contentious short-seller reportpresents a high-risk trap or a significant buying opportunity. Shareholders are heavily focused on the companys strong revenue growth, recent FDA label expansion for its core product, and management's aggressive share repurchase program, which many believe creates an artificial floor and potential for a sharp rebound.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is currently experiencing high volatility as investors balance excitement over AI-driven AGI CPU demand against concerns regarding supply chain constraints and a stretched valuation. The community remains heavily divided, with active debates centered on whether the company is a core AI infrastructure powerhouse or a speculative bubble due for a correction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

OPKO Health, Inc. (NASDAQ:OPK) Given Consensus Recommendation of "Hold" by Brokerages

OPKO Health, Inc. (NASDAQ:OPK - Get Free Report) has earned an average recommendation of 'Hold' from the six brokerages that are covering the company, Marketbeat reports. One investment analyst has...

HC Wainwright Boosts Earnings Estimates for OPKO Health

OPKO Health, Inc. (NASDAQ:OPK - Free Report) - Analysts at HC Wainwright lifted their FY2026 earnings estimates for shares of OPKO Health in a research note issued to investors on Wednesday, April...

Q1 Earnings Estimate for OPKO Health Issued By HC Wainwright

OPKO Health, Inc. (NASDAQ:OPK - Free Report) - Analysts at HC Wainwright issued their Q1 2027 earnings per share (EPS) estimates for shares of OPKO Health in a research report issued to clients and investors on Wednesday, April 29th. HC Wainwright analyst Y. Chen expects that the biotechnology compa...

OPKO Health Q1 Earnings In-Line on Product Gains, Revenues Down Y/Y

OPK's Q1 earnings match estimates as pharma product sales rose, but revenue slides 25.7% after a smaller BioReference diagnostics base.

OPKO Health (NASDAQ:OPK) Hits New 1-Year Low  - Should You Sell?

OPKO Health (NASDAQ:OPK) Reaches New 1-Year Low - What's Next...

OPKO Health Q1 2026 Earnings Call: Complete Transcript

OPKO Health Q1 Earnings Call Highlights

OPKO Health (NASDAQ:OPK) reported first-quarter 2026 results and highlighted continued progress across its ModeX Therapeutics pipeline, along with ongoing restructuring in diagnostics and growth in international pharmaceutical operations.

ModeX pipeline expands clinical activity and partnerships
Ch...

OPKO Health (OPK) Reports Q1 Loss, Misses Revenue Estimates

OPKO Health (OPK) delivered earnings and revenue surprises of -2.94% and -4.87%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

OPKO Health (OPK) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for OPKO Health (OPK) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

OPKO Health (NASDAQ:OPK) Announces Quarterly Earnings Results, Hits Estimates

OPKO Health (NASDAQ:OPK - Get Free Report) issued its quarterly earnings data on Tuesday. The biotechnology company reported ($0.07) earnings per share (EPS) for the quarter, hitting analysts...

OPKO Health, Inc. is a biopharmaceutical and diagnostics company, which engages in the provision of healthcare services. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment manages the clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Opko Health Inc

Still early innings

Overdone

Consolidation due before next leg up

Memory stocks have surged over the past year - is the run overdone or still early innings?

Current Price	$1.12
Prev Close	$1.13
Open	$1.14
Dividend Yield	0.00%
50-Day Moving Average	$1.17
Beta	0.96
Avg. Volume	2.3M
PE Ratio	-4.09

52-Week High	$1.60
52-Week Low	$0.9769
Market Capitalization	$853.25M
EPS (Annual)	-$0.3004
Price to Book	0.70
Revenue Per Employee	$266,760.00

OPK
Opko Health Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest OPK News

OPKOpko Health Inc